Yayın:
Frontiers in clinical immunology 2008

Basit Görünüm
dc.contributor.authorDeniz, Günnur
dc.contributor.authorZouali, Moncef
dc.contributor.buuauthorOral, Haluk Barbaros
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentMikrobiyoloji ve İmmünoloji Ana Bilim Dalı
dc.contributor.orcid0000-0003-0463-6818
dc.contributor.researcheridK-7285-2012
dc.contributor.scopusid7004498001
dc.date.accessioned2022-04-26T07:07:21Z
dc.date.available2022-04-26T07:07:21Z
dc.date.issued2009-08
dc.description.abstractIn recent years, investigations in immunology have led to progress in clinical medicine, including understanding transplant rejection, autoimmune diseases, immune deficiencies, inflammation, transplantation, cancer and the development of new vaccines. At a meeting recently held on the Mediterranean shore, advances in several facets of clinical immunology were the focus of discussion. Here, we highlight some of the debates that reflected advances in a variety of human immune disorders.
dc.description.sponsorshipEuropeanFederation of Immunological Societies (EFIS
dc.description.sponsorshipEJI, the International Union of Immunological Societies (IUIS)
dc.identifier.citationDeniz, G. vd. (2009). "Frontiers in clinical immunology 2008". Scandinavian Journal of Immunology, 70(2), 163-171.
dc.identifier.doi10.1111/j.1365-3083.2009.02284.x
dc.identifier.endpage171
dc.identifier.issn0300-9475
dc.identifier.issue2
dc.identifier.pubmed19630924
dc.identifier.scopus2-s2.0-67651246751
dc.identifier.startpage163
dc.identifier.urihttps://doi.org/10.1111/j.1365-3083.2009.02284.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1365-3083.2009.02284.x
dc.identifier.urihttp://hdl.handle.net/11452/26082
dc.identifier.volume70
dc.identifier.wos000268061600013
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalScandinavian Journal of Immunology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.relation.tubitakTÜBİTAK
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCommon variable immunodeficiency
dc.subjectExperimental sjogrens-syndrome
dc.subjectCd8(+) t-cells
dc.subjectRheumatoid-arthritis
dc.subjectPeptide at-1002
dc.subjectExpression
dc.subjectReceptor
dc.subjectDisease
dc.subjectTuberculosis
dc.subjectReplication
dc.subjectImmunology
dc.subject.emtreeAntigen
dc.subject.emtreeAntiretrovirus agent
dc.subject.emtreeB cell activating factor
dc.subject.emtreeBacterial toxin
dc.subject.emtreeBCG vaccine
dc.subject.emtreeBiological marker
dc.subject.emtreeCD40 antigen
dc.subject.emtreeCD40 ligand
dc.subject.emtreeCyclic AMP
dc.subject.emtreeCyclooxygenase 2
dc.subject.emtreeCyclosporin A
dc.subject.emtreeFc receptor IIb
dc.subject.emtreeGamma interferon
dc.subject.emtreeGranulocyte chemotactic protein 2
dc.subject.emtreeImmunoglobulin enhancer binding protein
dc.subject.emtreeImmunoglobulin G3
dc.subject.emtreeInterleukin 10
dc.subject.emtreeInterleukin 18
dc.subject.emtreeInterleukin 6
dc.subject.emtreeInterleukin 8
dc.subject.emtreeListeriolysin
dc.subject.emtreePhospholipase A2
dc.subject.emtreeProstaglandin E2
dc.subject.emtreeProtein arginine deiminase
dc.subject.emtreeRho kinase
dc.subject.emtreeTranscription factor NFAT
dc.subject.emtreeTransforming growth factor beta1
dc.subject.emtreeTransmembrane activator and CAML interactor
dc.subject.emtreeUnindexed drug
dc.subject.emtreeVpr protein
dc.subject.emtreeAcquired immune deficiency syndrome
dc.subject.emtreeApoptosis
dc.subject.emtreeAutoimmune disease
dc.subject.emtreeAutoimmunity
dc.subject.emtreeBacillus anthracis
dc.subject.emtreeBasophil
dc.subject.emtreeBCG vaccination
dc.subject.emtreeBehcet disease
dc.subject.emtreeBordetella pertussis
dc.subject.emtreeCancer immunization
dc.subject.emtreeCD8+ T lymphocyte
dc.subject.emtreeClinical immunology
dc.subject.emtreeCommon variable immunodeficiency
dc.subject.emtreeConference paper
dc.subject.emtreeDendritic cell
dc.subject.emtreeDNA polymorphism
dc.subject.emtreeDrug efficacy
dc.subject.emtreeDrug induced cancer
dc.subject.emtreeEndothelium cell
dc.subject.emtreeEpigenetics
dc.subject.emtreeGene
dc.subject.emtreeGene expression
dc.subject.emtreeGene mutation
dc.subject.emtreeGene therapy
dc.subject.emtreeGraft rejection
dc.subject.emtreeHemophagocytic lymphohistiocytosis
dc.subject.emtreeHighly active antiretroviral therapy
dc.subject.emtreeHistocompatibility
dc.subject.emtreeHuman
dc.subject.emtreeHuman immunodeficiency virus 1 infection
dc.subject.emtreeImmune deficiency
dc.subject.emtreeImmune response
dc.subject.emtreeImmunogenetics
dc.subject.emtreeImmunopathology
dc.subject.emtreeLung alveolus macrophage
dc.subject.emtreeMacrophage
dc.subject.emtreeMonocyte
dc.subject.emtreeMycobacterium tuberculosis
dc.subject.emtreeNatural killer cell
dc.subject.emtreeNonhuman
dc.subject.emtreePathogenicity
dc.subject.emtreePriority journal
dc.subject.emtreeProstate hypertrophy
dc.subject.emtreeProtein phosphorylation
dc.subject.emtreePseudomonas aeruginosa
dc.subject.emtreeRheumatoid arthritis
dc.subject.emtreeSignal transduction
dc.subject.emtreeSjoegren syndrome
dc.subject.emtreeSouthern Europe
dc.subject.emtreeSystemic lupus erythematosus
dc.subject.emtreeTuberculosis
dc.subject.emtreeTumor growth
dc.subject.scopusChimerism; Dizygotic Twins; Karyotype 46,Xx
dc.subject.wosImmunology
dc.titleFrontiers in clinical immunology 2008
dc.typeArticle
dc.type.subtypeEditorial Material
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Mikrobiyoloji ve İmmünoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Oral_vd_2009.pdf
Boyut:
96.96 KB
Format:
Adobe Portable Document Format
Açıklama
İndir

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications